Adrienne E Campbell-Washburn1, Yun Jiang2, Gregor Körzdörfer3, Mathias Nittka4, Mark A Griswold5. 1. Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, United States of America. Electronic address: adrienne.campbell@nih.gov. 2. Department of Radiology, Case Western Reserve University, Cleveland, OH, United States of America; Department of Radiology, University of Michigan, Ann Arbor, OH, United States of America. Electronic address: yunjiang@med.umich.edu. 3. Siemens Healthcare GmbH, Allee am Roethelheimpark 2, 91052 Erlangen, Germany. Electronic address: gregor.koerzdoerfer@siemens-healthineers.com. 4. Siemens Healthcare GmbH, Allee am Roethelheimpark 2, 91052 Erlangen, Germany. Electronic address: mathias.nittka@siemens-healthineers.com. 5. Department of Radiology, Case Western Reserve University, Cleveland, OH, United States of America. Electronic address: mag46@case.edu.
Abstract
BACKGROUND: MR fingerprinting (MRF) is a versatile method for rapid multi-parametric quantification. The application of MRF for lower MRI field could enable multi-contrast imaging and improve exam efficiency on these systems. The purpose of this work is to demonstrate the feasibility of 3D whole-brain T1 and T2 mapping using MR fingerprinting on a contemporary 0.55 T MRI system. MATERIALS AND METHODS: A 3D whole brain stack-of-spirals FISP MRF sequence was implemented for 0.55 T. Quantification was validated using the NIST/ISMRM Quantitative MRI phantom, and T1 and T2 values of white matter, gray matter, and cerebrospinal fluid were measured in 19 healthy subjects. To assess MRF performance in the lower SNR regime of 0.55 T, measurement precision was calculated from 100 simulated pseudo-replicas of in vivo data and within-session measurement repeatability was evaluated. RESULTS: T1 and T2 values calculated by MRF were strongly correlated to standard measurements in the ISMRM/NIST MRI system phantom (R2 > 0.99), with a small constant bias of approximately 5 ms in T2 values. 3D stack-of-spirals MRF was successfully applied for whole brain quantitative T1 and T2 at 0.55 T, with spatial resolution of 1.2 mm × 1.2 mm × 5 mm, and acquisition time of 8.5 min. Moreover, the T1 and T2 quantifications had precision <5%, despite the lower SNR of 0.55 T. CONCLUSION: A 3D whole-brain stack-of-spirals FISP MRF sequence is feasible for T1 and T2 mapping at 0.55 T.
BACKGROUND: MR fingerprinting (MRF) is a versatile method for rapid multi-parametric quantification. The application of MRF for lower MRI field could enable multi-contrast imaging and improve exam efficiency on these systems. The purpose of this work is to demonstrate the feasibility of 3D whole-brain T1 and T2 mapping using MR fingerprinting on a contemporary 0.55 T MRI system. MATERIALS AND METHODS: A 3D whole brain stack-of-spirals FISP MRF sequence was implemented for 0.55 T. Quantification was validated using the NIST/ISMRM Quantitative MRI phantom, and T1 and T2 values of white matter, gray matter, and cerebrospinal fluid were measured in 19 healthy subjects. To assess MRF performance in the lower SNR regime of 0.55 T, measurement precision was calculated from 100 simulated pseudo-replicas of in vivo data and within-session measurement repeatability was evaluated. RESULTS: T1 and T2 values calculated by MRF were strongly correlated to standard measurements in the ISMRM/NIST MRI system phantom (R2 > 0.99), with a small constant bias of approximately 5 ms in T2 values. 3D stack-of-spirals MRF was successfully applied for whole brain quantitative T1 and T2 at 0.55 T, with spatial resolution of 1.2 mm × 1.2 mm × 5 mm, and acquisition time of 8.5 min. Moreover, the T1 and T2 quantifications had precision <5%, despite the lower SNR of 0.55 T. CONCLUSION: A 3D whole-brain stack-of-spirals FISP MRF sequence is feasible for T1 and T2 mapping at 0.55 T.
Authors: Debra F McGivney; Eric Pierre; Dan Ma; Yun Jiang; Haris Saybasili; Vikas Gulani; Mark A Griswold Journal: IEEE Trans Med Imaging Date: 2014-07-10 Impact factor: 10.048
Authors: Peter de Blank; Chaitra Badve; Deborah Rukin Gold; Duncan Stearns; Jeffrey Sunshine; Sara Dastmalchian; Krystal Tomei; Andrew E Sloan; Jill S Barnholtz-Sloan; Adam Lane; Mark Griswold; Vikas Gulani; Dan Ma Journal: Pediatr Neurosurg Date: 2019-08-15 Impact factor: 1.162
Authors: Mathieu Sarracanie; Cristen D LaPierre; Najat Salameh; David E J Waddington; Thomas Witzel; Matthew S Rosen Journal: Sci Rep Date: 2015-10-15 Impact factor: 4.379
Authors: Nikolai J Mickevicius; Joshua P Kim; Jiwei Zhao; Zachary S Morris; Newton J Hurst; Carri K Glide-Hurst Journal: Med Phys Date: 2021-09-18 Impact factor: 4.071